PhRMA perspective on population and individual bioequivalence.
about
Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?The use of asymmetric distributions in average bioequivalence.Bioequivalence: tried and tested.Investigation of the bioequivalence of two lansoprazole formulations in healthy Chinese volunteers after a single oral administration.Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities
P2860
PhRMA perspective on population and individual bioequivalence.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
PhRMA perspective on population and individual bioequivalence.
@ast
PhRMA perspective on population and individual bioequivalence.
@en
type
label
PhRMA perspective on population and individual bioequivalence.
@ast
PhRMA perspective on population and individual bioequivalence.
@en
prefLabel
PhRMA perspective on population and individual bioequivalence.
@ast
PhRMA perspective on population and individual bioequivalence.
@en
P2093
P2860
P1476
PhRMA perspective on population and individual bioequivalence.
@en
P2093
Barrett JS
Patterson SD
Stritar JA
P2860
P304
P356
10.1002/J.1552-4604.2000.TB05980.X
P577
2000-06-01T00:00:00Z